ST. LOUIS, June 02, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced the completion of its acquisition of Bryan, Garnier & Co. (“Bryan Garnier”), a leading independent full-service investment bank specializing in the European technology and healthcare sectors. “Bryan Garnier brings focused sector expertise, an entrepreneurial mindset, and a strong reputation for trusted advice—qualities that align closely with Stifel’s values and strategy,” said Ronald J. Kruszewski, Chairman and C ...

VANCOUVER, BC, June 02, 2025 (GLOBE NEWSWIRE) -- Eat & Beyond Global Holdings Inc. (CSE: EATS) (OTCPK: EATBF) (FSE: 988) (“Eat & Beyond” or the “Company”), is pleased to announce that it is proposing a name change and an expansion of its Investment Policy to reflect a change in strategic focus. Proposed Name Change Subject to shareholder approval, the Company intends to change its name from “Eat & Beyond Global Holdings Inc.” to “Digital Asset Technologies Inc.”. The proposed name change is intended to repr ...

Company Overview - Nexxen International Ltd. is a global advertising technology platform specializing in data and advanced TV, offering a flexible and unified technology stack that includes a demand-side platform (DSP) and supply-side platform (SSP) [3][4] - The company is headquartered in Israel and has offices across the United States, Canada, Europe, and Asia-Pacific, and is traded on Nasdaq under the ticker NEXN [4] Share Repurchase Program - In May 2025, Nexxen repurchased 1,260,000 Ordinary Shares at an average price of $11.30 [1] - As of May 31, 2025, the company had 59,483,096 Ordinary Shares outstanding and approximately $24.8 million remaining under its current share repurchase program authorization [2]

Vancouver, BC, June 02, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp. (“New Wave” or the “Company”) (CSE:NWAI, FWB:0XM0, OTCPK:TRMNF) announces that Mr. Joshua Matettore has been appointed as Chief Executive Officer (“CEO”) of the Company effective immediately. Mr. Matettore succeeds Mr. Sunny Ray as CEO, following Mr. Ray’s resignation from the role, which the Company accepted effective today. Mr. Ray will remain a Director of the Company and will continue to work closely with the Company’s management t ...

VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Vancouver, BC (June 2, 2025) – Miata Metals Corp. (CSE: MMET) (FSE: 8NQ) (OTCQB:MMETF) (“Miata” or the “Company”) is pleased to announce that it has entered into an option agreement (the “Nassau Agreement”) with the registered owner (the “Optionor”) of the Nassau gold project in Suriname (“Nassau”), providing a path to increase the 70% interest currently held by the Company to 100%. “With this transaction, Miata now holds exposure to the potenti ...

Repeated doses of INB-200 demonstrate extended median progression-free survival (mPFS) of 16.1 months, more than double the expected 6.9 months typically observed with the standard-of-care (SOC) Stupp protocolINB-200 is well-tolerated, showing no serious toxicities beyond those typically observed with chemotherapy. Importantly no cytokine release syndrome (CRS), or immune effector cell-associated neurotoxicity syndrome (ICANS) was observedMedian PFS in patients receiving multiple doses of INB-200 exceeds th ...

Dr Manfred Knof Dr. Manfred Knof, former Commerzbank CEO, joins DeFi Technologies as Strategic Advisor and Chairman of Valour, bringing decades of leadership in European banking. DeFi Technologies appoints former Commerzbank CEO Dr. Manfred Knof as Strategic Advisor to DeFi Technologies and Chairman of Valour, bringing decades of executive leadership experience in European banking and finance.Dr. Knof will drive global growth and institutional expansion for Valour by leveraging his extensive industry ne ...

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. MIAMI, June 02, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), an innovative energy infrastructure company that develops cutting-edge data centers, is pleased to provide unaudited comparative Bitcoin (“BTC”) production results for the month ended May 31, 2025, ...

Dosing cohort 3 of Phase 1 trial of CTIM-76, a Claudin 6 x CD3 T cell engager Expect to share initial data in the first half of 2026 PHILADELPHIA, June 02, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors, announced today that it is presenting a Trial in Progress poster for the Phase 1 clinical trial evaluating CTIM-76 in ovarian, endometrial, and tes ...

Company Overview - BridgeBio Pharma, Inc. is a biopharmaceutical company focused on discovering, creating, testing, and delivering transformative medicines for genetic diseases [3] - Founded in 2015, the company has a pipeline that includes programs from early science to advanced clinical trials [3] - The team consists of experienced drug discoverers, developers, and innovators dedicated to applying advances in genetic medicine [3] Upcoming Event - Members of BridgeBio's management team will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 on June 9 at 8:40 am ET [1] - A live webcast of the presentation will be available on the company's website, with a replay accessible for 30 days post-event [2]